Description

• Adjusting your institution’s risk model in lieu of recent MRB legal developments, such as the lawful sale of CBD products on a federal level, while meeting regulatory expectations

• Crafting and conducting business side training on typologies such as commingling of bankable and non-bankable proceeds in order to strengthen monitoring of institutional risks related to marijuana

• Formalizing protocols for reviewing MRB policies and procedures to ensure oversight practices area current and reflect institutional risk appetite and tolerance

https://dvg.ca1.qualtrics.com/jfe/form/SV_8jDMO6LiQ48JV5j

Moderator(s):

• Michael S. Schidlow, CAMS-Audit, Head of FCC and Emerging Risk Audit Development Global Internal Audit, HSBC

Speaker(s):

• Lindsay M. Dastrup, CAMS-Audit, CAMS-FCI, Vice President, Audit Leader, American Express
• Michael Greenman, Senior Vice President, Chief Counsel, AML and Economic Sanctions Law, U.S. Bank
• Dan Stipano, Partner, Buckley Sandler LLP